Third Harmonic Bio, Inc. (THRD)
USD 3.6
(3.75%)
USD 3.6
(3.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -20.42 Million | -34.91 Million | -15.74 Million | -9.18 Million |
| Net Income | -30.82 Million | -35.15 Million | -29.6 Million | -12.8 Million |
| Depreciation & Amortization | 35 Thousand | 1000.00 | - | - |
| Deferred income taxes | 249 Thousand | - | - | - |
| Stock-based compensation | 9.57 Million | 4.75 Million | 510 Thousand | 195 Thousand |
| Change in working capital | 223 Thousand | -4.55 Million | 2.74 Million | 1.73 Million |
| Other non-cash items | 315 Thousand | 37 Thousand | 10.61 Million | 1.68 Million |
| Investing Cash Flow | -169 Thousand | -36 Thousand | - | - |
| Investments in PPE | -169 Thousand | -36 Thousand | - | - |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | - | - | - |
| Financing Cash Flow | 799 Thousand | 195.99 Million | 135.74 Million | 10.82 Million |
| Debt repayment | - | - | - | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 799 Thousand | 198.17 Million | 135.74 Million | 10.82 Million |
| Other Financing Activities | 799 Thousand | -2.18 Million | 135.74 Thousand | 10.82 Thousand |
| Accounts receivables | - | - | - | - |
| Accounts payables | -249 Thousand | 290 Thousand | 1.21 Million | 324 Thousand |
| Inventory | - | - | - | - |
| Other working capital | 472 Thousand | -4.84 Million | 1.52 Million | 1.41 Million |
| Cash at beginning of period | 288.87 Million | 128.28 Million | 8.27 Million | 6.63 Million |
| Cash at end of period | 269.07 Million | 289.31 Million | 128.28 Million | 8.27 Million |
| Capital Expenditure | -169 Thousand | -36 Thousand | - | - |
| Effect of forex changes on cash | -12 Thousand | - | - | - |
| Net cash flow / Change in cash | -19.8 Million | 161.03 Million | 120 Million | 1.63 Million |
| Free Cash Flow | -20.59 Million | -34.95 Million | -15.74 Million | -9.18 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.7 Million | -7.85 Million | -30.82 Million | -6.83 Million | -7.34 Million | -7.56 Million |
| Depreciation & Amortization | 12 Thousand | 12 Thousand | 35 Thousand | 13 Thousand | 12 Thousand | 7000.00 |
| Deferred income taxes | - | - | 249 Thousand | -1.89 Million | - | - |
| Stock-based compensation | 2.6 Million | 2.22 Million | 9.57 Million | 1.75 Million | 2.29 Million | 2.84 Million |
| Change in working capital | -899 Thousand | -846 Thousand | 223 Thousand | -711 Thousand | 691 Thousand | 587 Thousand |
| Other non-cash items | 2.31 Million | 3.31 Million | 315 Thousand | 2.06 Million | 166 Thousand | 161 Thousand |
| Investing Cash Flow | - | - | -169 Thousand | -1000.00 | - | -168 Thousand |
| Investments in PPE | - | - | -169 Thousand | -1000.00 | - | -168 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.31 Million | 49 Thousand | 799 Thousand | 798 Thousand | -57 Thousand | 58 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.31 Million | 49 Thousand | 799 Thousand | 798 Thousand | -57 Thousand | 58 Thousand |
| Other Financing Activities | 1.31 Million | 49 Thousand | 799 Thousand | 798 Thousand | -57 Thousand | 58 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 494 Thousand | -893 Thousand | -249 Thousand | -108 Thousand | 603 Thousand | -1.31 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.39 Million | 47 Thousand | 472 Thousand | -603 Thousand | 88 Thousand | 1.9 Million |
| Cash at beginning of period | 262.82 Million | 269.07 Million | 288.87 Million | 273.89 Million | 278.57 Million | 282.64 Million |
| Cash at end of period | 255.33 Million | 262.82 Million | 269.07 Million | 269.07 Million | 274.33 Million | 278.57 Million |
| Capital Expenditure | - | - | -169 Thousand | -1000.00 | - | -168 Thousand |
| Effect of forex changes on cash | - | - | -12 Thousand | -12 Thousand | - | 11.63 Million |
| Net cash flow / Change in cash | -7.49 Million | -6.24 Million | -19.8 Million | -4.82 Million | -4.24 Million | -4.07 Million |
| Free Cash Flow | -8.8 Million | -6.29 Million | -20.59 Million | -5.6 Million | -4.18 Million | -4.12 Million |
600261
CLIME-B
BRE
WMLLF
000590
MSBHF